Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis

被引:56
作者
Filiopoulos, Vassilis [1 ]
Hadjiyannakos, Dimitrios [1 ]
Takouli, Lambrini [1 ]
Metaxaki, Polixeni [1 ]
Sideris, Vasilis [2 ]
Vlassopoulos, Dimosthenis [1 ]
机构
[1] Amalia Fleming Hosp, Dept Nephrol, Athens 14121, Greece
[2] Pendeli Pediat Hosp, Dept Hematol, Athens, Greece
关键词
End-stage renal disease; Hemodialysis; Peritoneal dialysis; Inflammation; Oxidative stress; C-REACTIVE-PROTEIN; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HYPERHOMOCYSTEINEMIA; MICROINFLAMMATION; DYSLIPIDEMIA; SERUM; IRON;
D O I
10.1177/039139880903201206
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Purpose: The impact of different dialysis modalities on oxidative stress and inflammation and the factors implicated in this interrelationship have not been adequately studied. This study was designed to comparatively evaluate the effect of hemodialysis (HD) and peritoneal dialysis (PD) on oxidative stress and inflammatory biomarkers and to search for associated factors. Methods: We studied 20 HD, 11 PD patients and 11 healthy controls. Calculations were based on total antioxidant capacity (TAC) and superoxide dismutase (SOD), by spectrophotometry, as oxidative stress biomarkers; and high sensitivity CRP (hs-CRP), Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), by ELISA, as inflammation biomarkers. Results: HD and PD patients showed significantly increased levels of TAC, SOD and hs-CRP compared to healthy controls. No significant difference was observed in TNF-alpha and IL-6. Compared to HD patients, PD patients showed TNF-alpha levels that were increased, although non-significantly, and significantly higher homocysteine (Hcy). No differences were observed for IL-6, hs-CRP, TAC and SOD. In HD patients, significant positive correlations were found between intact parathyroid hormone (iPTH) and TNF-alpha, and between uric acid (UA) and TAC. beta 2-microglobulin (beta 2M) was negatively correlated with TAC, total cholesterol (TC) positively with TNF-alpha and negatively with SOD, and triglycerides (TG) correlated positively with TNF-alpha. In PD patients, TG correlated positively with TNF-alpha, HDL-cholesterol negatively with TNF-alpha, LDL-cholesterol negatively with SOD, and beta 2M negatively with SOD. Conclusions: HD and PD patients show similar degrees of inflammation and oxidative stress activation. Factors such as UA, iPTH, beta 2M and lipid profile correlate to oxidative stress and inflammatory biomarkers in both HD and PD patients. (Int J Artif Organs 2009; 32: 872-82)
引用
收藏
页码:872 / 882
页数:11
相关论文
共 41 条
[1]
Immunological basis of inflammation in dialysis [J].
Amore, A ;
Coppo, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :16-24
[2]
The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[3]
The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels [J].
Borazan, A ;
Ustün, H ;
Ustundag, Y ;
Aydemir, S ;
Bayraktaroglu, T ;
Sert, M ;
Yilmaz, A .
MEDIATORS OF INFLAMMATION, 2004, 13 (03) :201-204
[4]
Imbalance of oxidants and antioxidants in haemodialysis patients [J].
Canaud, B ;
Cristol, JP ;
Morena, M ;
Leray-Moragues, H ;
Bosc, JY ;
Vaussenat, F .
BLOOD PURIFICATION, 1999, 17 (2-3) :99-106
[5]
Being an inflamed peritoneal dialysis patient -: A Dante's journey [J].
Carrero, Juan Jesus ;
Axelsson, Jonas ;
Avesani, Carla Maria ;
Heimburger, Olof ;
Lindholm, Bengt ;
Stenvinkel, Peter .
PERITONEAL DIALYSIS: A CLINICAL UPDATE, 2006, 150 :144-151
[6]
Daugirdas J T, 1995, Adv Ren Replace Ther, V2, P295
[7]
De Vecchi AF, 2000, PERITON DIALYSIS INT, V20, P169
[8]
Two different modalities of iron gluconate i.v. administration: effects on iron, oxidative and inflammatory status in peritoneal dialysis patients [J].
de Vecchi, Amedeo F. ;
Novembrino, Cristina ;
Lonati, Silvia ;
Ippolito, Silvia ;
Bamonti, Fabrizia .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) :1709-1713
[9]
C-reactive protein and cardiovascular disease in peritoneal dialysis patients [J].
Ducloux, D ;
Bresson-Vautrin, C ;
Kribs, M ;
Abdelfatah, A ;
Chalopin, JM .
KIDNEY INTERNATIONAL, 2002, 62 (04) :1417-1422
[10]
Fortes PC, 2007, PERITON DIALYSIS INT, V27, pS76